Benefits of deacetylase inhibitors for leukemia therapy
RESONATE, RESONATE-2 and HELIOS: three major clinical trials in CLL research
Thomas J. Kipps
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al.
CLL highlights from ASCO 2016: HELIOS trial, CAR T-cell therapy and CLL-IPI